List/Grid

Tag Archives: Immunology

Combination peptide therapies might offer more effective, less toxic cancer treatment

Combination peptide therapies might offer more effective, less toxic cancer treatment

ScienceDaily (Aug. 16, 2012) — Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments. Continue reading

Gut bacteria linked to obesity and metabolic syndrome identified

Gut bacteria linked to obesity and metabolic syndrome identified

ScienceDaily (Aug. 15, 2012) — Researchers at the University of Maryland School of Medicine have identified 26 species of bacteria in the human gut microbiota that appear to be linked to obesity and related metabolic complications. Continue reading

Vaccine targets malignant brain cancer antigens, significantly lengthens survival

Vaccine targets malignant brain cancer antigens, significantly lengthens survival

ScienceDaily (Aug. 15, 2012) — An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Immunotherapy , published online Aug. 3 Continue reading

Vaccine targets malignant brain cancer antigens, significantly lengthens survival

Vaccine targets malignant brain cancer antigens, significantly lengthens survival

ScienceDaily (Aug. 15, 2012) — An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Immunotherapy , published online Aug. 3 Continue reading

Blood cancer cells initiate signalling cascade

Blood cancer cells initiate signalling cascade

ScienceDaily (Aug. 13, 2012) — Freiburg scientists have uncovered how pathological cells activate themselves in chronic lymphocytic leukemia. Researchers in the group of Prof. Continue reading

Infants exposed to specific molds have higher asthma risk

Infants exposed to specific molds have higher asthma risk

ScienceDaily (Aug. 2, 2012) — In the United States, one in 10 children suffers from asthma but the potential environmental factors contributing to the disease are not well known. Cincinnati-based researchers now report new evidence that exposure to three types of mold during infancy may have a direct link to asthma development during childhood Continue reading

Cell receptor has proclivity for T helper 9 cells, airway inflammation

Cell receptor has proclivity for T helper 9 cells, airway inflammation

ScienceDaily (July 29, 2012) — A research team led by Xian Chang Li, MD, PhD, Brigham and Women’s Hospital (BWH) Transplantation Research Center, has shed light on how a population of lymphocytes, called CD4+ T cells, mature into various subsets of adult T helper cells. Continue reading

Discovery of new white blood cell reveals target for better vaccine design

Discovery of new white blood cell reveals target for better vaccine design

ScienceDaily (July 27, 2012) — Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source — providing a new potential target for vaccines for conditions such as cancer or Hepatitis B. Publishing in the journal Immunity , the team of researchers from Newcastle University in collaboration with A*STAR’s Singapore Immunology Network (SIgN) describe a new human tissue dendritic cell with cross-presenting function. Dendritic cells (DCs) are a type of white blood cell that orchestrate our body’s immune responses to infectious agents such as bacteria and viruses, as well as cancer cells. Continue reading

New class of synthetic vaccines explored

New class of synthetic vaccines explored

ScienceDaily (July 25, 2012) — In a quest to make safer and more effective vaccines, scientists at the Biodesign InstituteÒ at Arizona State University have turned to a promising field called DNA nanotechnology to make an entirely new class of synthetic vaccines. Continue reading

New target for vaccine development in abundant immune cells

New target for vaccine development in abundant immune cells

ScienceDaily (July 24, 2012) — White blood cells called neutrophils, which are the first line of defense against infection, play an unexpected role by boosting antibody production, according to research led by Mount Sinai School of Medicine. The findings suggest neutrophils have multiple roles within the immune system and function at levels previously unknown to the scientific community Continue reading